skip to Main Content
A self-proclaimed "Kansas Girl," Carey Gillam (shown here with NHL patient and plaintiff Lee Johnson) is an investigative journalist and author who has dedicated her career to understanding the risks and rewards of the modern-day food system.

Archived Blog Posts
  • Eaters Deserve More Complete Information About Nutrition and Health Impacts on Food Labels  

    Multiple lines of evidence point to consumer food choices as major contributors to diet-related disease, and poor health and fitness. In a peer-reviewed journal article published today, authors Chuck Benbrook and Robin Mesnage cite studies indicating that “Some 90% of the estimated USD 4.3 trillion in annual health care costs in the US is triggered or made worse by poor food quality and diet-related disease.” Benbrook is the founder and former executive director of the Heartland Health Research Alliance (HHRA). The authors recommend novel metrics on both the nutrient density of food, and how to more accurately and usefully characterize the degree of food processing and its impacts on public health. The article is open access in the journal Foods and entitled “Enhanced Labeling to Promote Consumption of Nutrient Dense Foods and Healthier Diets.” The core nutrient density metric is a ratio: the percent of daily nutrient needs satisfied by a serving of food relative to the percent of a 2000 calorie daily diet taken up by the serving of food. This single metric is unmatched in comprehensively reflecting the nutritional quality of food. A graphic option to convey the metric on packaging is presented in Figure 3 in the new paper: A novel graphic is presented in Figure 5 to which integrates both the nutrient density and food processing metrics and graphics in a single graphic, shown below. The impacts of ultra-processed food (UPF) on public health outcomes is among the hottest topics in nutrition, medical, and public health journals, and media coverage on food quality and health outcomes. At the request of the journal, the authors developed a video abstract that explains the paper’s goals, methods, and key findings and recommendations. The authors conclude their paper with these observations: Transparent and accurate food product-specific ingredient and nutrient composition data should determine the content of nutrition health labeling. Efforts to soften the message should be resisted in light of the overwhelming need for new food labels that help bring about substantial improvements in food nutritional quality and dietary choices. Benbrook and Mesnage’s paper builds on public comments HHRA submitted in response to the US Food and Drug Administration (FDA) proposed rule in 2023 to update the definition of the term “healthy” on food labels. The proposed role would require foods labeled “healthy” to contain minimum amounts of foods recommended by USDA’s Dietary Guidelines, and to limit saturated fat, sodium, added sugar and other less healthy nutrients. Entitled “Food Labeling: Nutrient Content Claims; Definition of Term `Healthy’”, the comments recommended new  nutrition/health messaging on the front of food packaging. Co-authors of comments included the chair of HHRA’s Policy Advisory committee Dr. Kathleen Merrigan, HHRA science advisors, and other experts working on how changes in farming systems and technology can increase the nutritional quality of food: Dr. Hannah Flower, Dr. Donald R. Davis, Dr. David Montgomery and Anne Biklé. In the comments, the authors introduced “NuCal” as a name for their new system. Resources HHRA February 2023 comments to the FDA. Benbrook and Mesnage (2024). Enhanced Labeling to Promote Consumption of Nutrient Dense Foods and Healthier Diets, Foods. https://doi.org/10.3390/foods13213377 Video Abstract: “Enhanced Labeling to Promote Consumption of Nutrient Dense Foods and Healthier Diets”

  • HHRA Weighs in on Key Pesticide Issues Under Review by the National Organic Standards Board

    HHRA and ORG-Tracker, represented by Dr. Chuck Benbrook and Dr. Brian Baker, submitted comments to the Agricultural Marketing Service at the USDA in advance of the National Organic Standards Board (NOSB) meeting in Portland, Oregon, from October 22nd to 24th, 2024. Drs. Benbrook and Baker will both attend the conference and deliver public comments. ORG-Tracker is a project carried out by HHRA. It aggregates pesticide residue data from inspections of organic farms carried out by certifiers. The tables generated by ORG-Tracker utilize the results of certifier testing to compare residue frequency and risk levels to food produced on conventional farms. The team is working to more effectively highlight gaps and challenges faced by certification agencies to answer questions like What crops should we be testing, and where? Is a pesticide residue found in an organic sample likely caused by accident, pesticide drift, or an intentional and illegal application? How can we modify organic programs to better mitigate risk? The comments delivered to the USDA discuss risk-based certification, pesticide residue testing, and policies impacting the incorporation of so-called inert ingredients in the biopesticides approved for use on organic farms. They argue for a more rigorous, comprehensive, and health-focused approach to risk oversight. Regarding residue testing, they advocate for more expansive and effective data aggregation to inform consumers and the organics community. Finally, for inert ingredients, they recommend further review of current policy, including increased transparency of ingredients in pesticide products. Thank you to Drs. Benbrook and Baker for your advocacy and hard work!   The three sets of comments are posted on HHRA’s website as part of our policy program: Comments to the NOSB on the Risk-Based Certification Discussion Document Under Consideration During the October 2024 Meeting in Portland, Oregon Written Comments on the NOSB Discussion Document “Residue Testing for the Global Supply Chain” Comments on the Inert Ingredients in Organic Pesticide Products Proposal dated August 13, 2024   Drs. Benbrook and Baker also submitted and presented comments at the Spring 2024 meeting of the NOSB, which are available on HHRA’s Policy and Regulatory Reform page.

  • Dr. Kimberly Yolton joins HHRA board

    Dr. Yolton is a developmental psychologist and epidemiologist serving as Professor of Pediatrics at Cincinnati Children’s Hospital Medical Center. Her interests include exposures and experiences that may alter a child’s developmental trajectory from infancy through adolescence. She collaborates on research projects on typical child development as well as those focused on the impact of exposures to environmental toxicants, opiates and stress during early development.

  • Paul Hartnett, HHRA’s Executive Director

      Paul Hartnett has served as HHRA’s CFO since our founding . With the departure of Russell King, Paul has now joined the board and Executive Director. We thank Russell for his service and wish him the best in his future endeavors.

  • Heartland Study Enrolls 1,000th Mother-Infant Pair

    July 19, 2024 – In June of this year, the Heartland Study achieved a major milestone, enrolling its 1,000th mother-infant pair. Enrollment is now at 50% of goal. The objective of the Study is to help fill major gaps in our understanding of the impacts of herbicides on maternal and infant health. Currently in Phase 1, the Study is focused on evaluating associations between herbicide concentrations in body fluids and tissue samples from pregnant women and infants, and pregnancy/childbirth outcomes. Phase 2 is designed to evaluate potential associations between herbicide biomarkers and early childhood neurological development. Much appreciation for the mothers enrolled, and the entire Heartland Study Team including scientists, support staff and clinicians for this tremendous achievement, and for our funders to making this work possible. Read more about the study including peer-reviewed studies published in Chemosphere and Agrichemicals at our publications  page. The investment required to conduct this study exceeds $1 million each year. You can support this important work by making a donation here.

Q & A with Journalist Carey Gillam on New Book “The Monsanto Papers”

Feb 19th, 2021
Feb 19th, 2021
A self-proclaimed "Kansas Girl," Carey Gillam (shown here with NHL patient and plaintiff Lee Johnson) is an investigative journalist and author who has dedicated her career to understanding the risks and rewards of the modern-day food system.

HHRA chatted with journalist Carey Gillam, author of the new book The Monsanto Papers: Deadly Secrets, Corporate Corruption, and One Man’s Search for Justice; Island Press, Release Date: March 2, 2021 

HHRA: Your first book, titled Whitewash, was described by one reviewer as a “hard-hitting” expose about Monsanto and the health and environmental risks of its best-selling Roundup herbicide. How does The Monsanto Papers compare?

Gillam: Whitewash was a book about long-hidden science and the company’s deception about the dangers its products pose. The Monsanto Papers is the very tragic human story about the results of that deception. This new book takes readers into the personal and painful struggle of Lee Johnson (pictured here with Carey)—an average middle-aged husband and father—as he sees his life unravel due to his terminal cancer diagnosis and tries to prepare his wife and two children for his death. The book also explores the fascinating—and controversial—tactics of the mass tort attorneys who decide to help Lee, and thousands of others like him, take Monsanto to court.

HHRA: You say The Monsanto Papers tells the inside story of Lee Johnson’s 2018 lawsuit and trial against Monsanto. Why was this such a landmark case?

Gillam: Lee became the first person in the world to go to trial against Monsanto and to prove that the company’s 40-year-old, wildly popular weed killer causes a type of cancer called non-Hodgkin lymphoma. Though many scientists for years had pointed to evidence tying Monsanto’s Roundup herbicide to cancer, the company had always been successful in convincing regulators and customers that such evidence was invalid. Few onlookers thought Lee and his lawyers could actually win at trial against the powerful and highly influential Monsanto. But people around the world wanted to see the evidence, and the case ended up being covered by media from around the world.

HHRA: Why is this book timely?

Gillam: Monsanto owner Bayer AG is now attempting to resolve more than 100,000 cases by paying out over $11 billion in settlements, but many thousands of plaintiffs continue to try to press forward with their claims that Monsanto’s weedkillers cause their cancers.

“The Monsanto Papers” will be available in early March 2021.

HHRA: Why did you write the book, and for whom?

Gillam: This book is written for all those who want to know more about the secrets kept by companies peddling dangerous products. It’s also written for those who suffer from cancers and other diseases caused by products and substances we’ve been told are safe, but which we belatedly learn are not safe at all. The corporate wrong-doing exposed through Lee’s trial and subsequent actions in the litigation provides a cautionary tale for consumers.

HHRA: One gripping chapter in the book describes Lee’s lawyers leaking internal Monsanto documents just after midnight to a journalist who makes them all public the next morning. You were that journalist. Did you have any concerns about publishing the documents? Why did you decide it was important for the public to see those documents?

Gillam: I had no concerns about publishing the documents at all. Corporations peddling products to millions of people around the world have a moral obligation to be truthful about the safety of those products, and I knew the internal company records would help people understand what actually was true and not true in this case. I did rush to get the documents downloaded and posted on a public website before dawn broke because I feared Monsanto might try to take court action against the law firm to force the firm to pull the documents from public view. Once I put them up I was not going to take them down.

HHRA: Your reporting is based on nearly unfettered access to Lee and his lawyers, and more than 80,000 pages of court exhibits and other documents. Did you discover anything in the course of that research that stands out or surprised you?

Gillam: Given my work writing Whitewash, I was already familiar with a lot of the evidence of corporate manipulation of the science, but the secrets that came to light when Monsanto had to turn over its internal emails to Lee’s lawyers were stunning. The Monsanto Papers takes readers into the law offices as the attorneys went through the company records for the first time, finding out about the company’s plot to kill a government toxicity review of its product; about the fact that Monsanto never conducted studies to see if the products sold to consumers caused cancer and avoided or ignored numerous warning signs about product dangers to human health. The lengths the company went to in order to discredit and harass independent scientists was also quite stunning. And the fact that all this went on for decades made it so much more damning.

HHRA: What do you hope readers take away from The Monsanto Papers?

Gillam: I hope readers are moved by Lee’s personal journey and motivated to understand that this story of one man and one company is really just a microcosmic example of a pressing need for greater protection of public health from the dangers of powerful corporations that put profits before people.

See more about the book here. Buy the book at AmazonBarnes & Noble, publisher Island Press or independent book sellers.

Follow Gillam on Twitter @careygillam

Back To Top